Crown Oak Advisors’s Idexx Laboratories IDXX Stock Holding History

Crown Oak Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.15M	Buy	+7,892	New	+$4.43M	1.93%	17

Other funds holding IDXX

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

WJWM

Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Crown Oak Advisors's IDXX Position: Q2 2026 in Review

Crown Oak Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 7,892 shares worth $4.15M. The stake represents 1.93% of the portfolio and ranks #17 among its holdings.

658 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Crown Oak Advisors held 7,892 shares of Idexx Laboratories worth $4.15M as of Q2 2026.
Idexx Laboratories was a new Crown Oak Advisors position in Q2 2026.
Idexx Laboratories made up 1.93% of Crown Oak Advisors's portfolio in Q2 2026, its #17 holding.
658 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Crown Oak Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.